patients diagnosed of having scabies. Scabies
Conditions
Interventions
Intervention 1: Group A (50 patients): Treated by application of topical formulation of moxidectin (Cydectin®) once. Intervention 2: Control group: Group B (50 patients): Treated by application of top
Sponsors
Faculty of Medicine, Tanta University
Eligibility
Sex/Gender
All
Age
No minimum to 60 Years
Inclusion criteria
Inclusion criteria: (A) Clinical: 1. Intense pruritus especially at night. 2. Typical distribution of the excoriated papulovesicular lesions; around umbilicus, flexures, genitalia, interdigital spaces. 3. Affection of other family members. (B) Parasitological: By detection of Sarcoptes Scabeii mites (adult, larvae and eggs) in cutaneous scrapings.
Exclusion criteria
Exclusion criteria: Patients with recent topical or systemic treatments of scabies. Patients with clinical bacterial infection or any other associated skin disease. Patients with any evident systemic diseases causing pruritus. Pregnant and lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical lesions and degree of pruritus. Timepoint: 1 week after intervention. Method of measurement: Clinical evaluation.;Mites count. Timepoint: 1 week after intervention. Method of measurement: Microscopic examination of mites. | — |
Countries
Egypt
Contacts
Public ContactDr. Mohamed Fawzy
Tanta University
Outcome results
None listed